NIH-funded research Fellowship grant

New treatments for opioid addiction

Official title: Novel Therapeutics for Treating Opioid Use Disorder

Funded at Virginia Commonwealth University · NIH-11071519 · Data updated 2026-11-12

This study is looking at a new way to help people with Opioid Use Disorder by testing a drug called Nor-Levo-α-acetylmethadol (nor-LAAM) to see if it can provide better and safer treatment options than what’s currently available.

More Opioid Use research and trials

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionVirginia Commonwealth University
NIH-funded
Lab location1 site (Richmond, United States)
Project startJune 10, 2025
Project endJune 9, 2027
Funding year2025
Award (this year)$48,974
NIH project number1F31DA060668-01A1
Project IDNIH-11071519 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Opioid Use Disorder who are seeking alternative treatment options.

Less likely to help

Patients who are not struggling with opioid addiction or those who have contraindications to the study medications may not benefit from this research.

What this research studies

This research focuses on developing innovative therapies for Opioid Use Disorder (OUD), a serious condition affecting many individuals. The project aims to explore the potential of Nor-Levo-α-acetylmethadol (nor-LAAM), a metabolite of an existing drug, to improve treatment outcomes. By optimizing drug delivery methods, the research seeks to enhance the effectiveness of therapies while minimizing side effects, such as cardiovascular risks associated with current treatments. Patients may benefit from a more effective and safer alternative to existing OUD medications.

Why it matters

Potential benefit: If successful, this research could provide patients with more effective and safer treatment options for opioid addiction.

How similar studies have gone: Previous research has shown promise in using similar approaches to improve treatment for opioid addiction, indicating potential for success in this area.

Where this research is happening

  • Virginia Commonwealth University
    Richmond, United States
    Active

Researchers

  • Principal investigator: Ingabire, Diane — Virginia Commonwealth University
  • Study coordinator: Ingabire, Diane

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.